chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023805 Size: 9 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023807 Size: 9 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023810 Size: 9 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023813 Size: 9 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 4.01, 5.03, 8.01, and 9.01 Accession Number: 0001104659-20-043432 Act: 34 Size: 72 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-022613 Size: 4 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-022588 Size: 4 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-022591 Size: 4 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-022574 Size: 4 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 5.02, 5.05, 7.01, and 9.01 Accession Number: 0001104659-20-038343 Act: 34 Size: 60 KB 网页链接